Ofatumumab
Ofatumumab is a fully human monoclonal antibody to CD20 which appears to inhibit early-stage B lymphocyte activation.
Product Specifications
CAS Number
679818-59-8
Stability
≥ 2 years
Purity
>98% (HPLC)
Weight
149 kDa
Molecular Formula
——
Notes
Research use only, not for human use.
Receptor
Other Targets
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog